Galimedix Therapeutics Inc
Galimedix Therapeutics Inc
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD | Geographic Atrophy, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 2 | 2026-10-05 | NCT06659549 | |
| A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid | Not yet recruiting | Phase 2 | 2026-08-27 | NCT07789873 |